AlloVir

0 followers

AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Industries

Employees

51-200

Links


Org chart

Chief Scientific Officer
Collapse
Vp, Biometrics
Senior Medical Director Clinical Development
Executive Director, R&d Counsel

Board & advisors

Advisor
Director
Director
Director
Executive Chairman
Advisor
Advisor
Advisor
Advisor
Advisor